Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2006

01-10-2006

Hemorrhagic Cystitis in Adults after Unrelated Cord Blood Transplantation: A Single-Institution Experience in Japan

Authors: Akira Tomonari, Satoshi Takahashi, Jun Ooi, Kenji Fukuno, Kashiya Takasugi, Nobuhiro Tsukada, Takaaki Konuma, Nobuhiro Ohno, Kaoru Uchimaru, Tohru Iseki, Arinobu Tojo, Shigetaka Asano

Published in: International Journal of Hematology | Issue 3/2006

Login to get access
Metadata
Title
Hemorrhagic Cystitis in Adults after Unrelated Cord Blood Transplantation: A Single-Institution Experience in Japan
Authors
Akira Tomonari
Satoshi Takahashi
Jun Ooi
Kenji Fukuno
Kashiya Takasugi
Nobuhiro Tsukada
Takaaki Konuma
Nobuhiro Ohno
Kaoru Uchimaru
Tohru Iseki
Arinobu Tojo
Shigetaka Asano
Publication date
01-10-2006
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2006
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.05169

Other articles of this Issue 3/2006

International Journal of Hematology 3/2006 Go to the issue

OriginalPaper

Overexpression of Interleukin 21 Induces Expansion of Hematopoietic Progenitor Cells

OriginalPaper

Surveillance of Active Human Herpesvirus 6 Infection in Chinese Patients after Hematopoietic Stem Cell Transplantation with 3 Different Methods

Case report

Late-Onset Neutropenia in Patients Treated with Rituximab for Non-Hodgkin’s Lymphoma

Progress in hematology

Phagocytosis-Coupled Activation of the Superoxide-Producing Phagocyte Oxidase, a Member of the NADPH Oxidase (Nox) Family

OriginalPaper

Promoter Hypermethylation of the DNA-Repair Gene O 6 -Methylguanine—DNA Methyltransferase and p53 Mutation in Diffuse Large B-cell Lymphoma

OriginalPaper

Synergistic Effect of Arsenic Trioxide and Flt3 Inhibition on Cells with Flt3 Internal Tandem Duplication
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits